Glenmark Pharmaceuticals per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹63.71₹48.26₹37.11−₹53.22₹10.53
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹63.69₹48.24₹37.10−₹53.22₹10.53
₹372.51₹372.51₹313.60₹278.11₹335.75
₹628.51₹601.79₹472.08₹418.62₹460.36
—₹122.08−₹29.33−₹9.41₹22.16
₹73.97₹73.97−₹55.89−₹41.24₹0.62
—₹5.00₹2.50₹4.17₹4.84
28.228.228.228.228.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

GLENMARK₹2,300.00

Glenmark Pharmaceuticals Ltd.

· Pharma & Health
₹ CrorePeersDRREDDYLUPINALKEMBIOCONMANKINDLAURUSLABSFORTISAUROPHARMAMcap ₹64,906 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS10.53-53.2237.1148.2663.71
Diluted EPS10.53-53.2237.1048.2463.69
Book Value per Share335.75278.11313.60372.51372.51
Revenue per Share460.36418.62472.08601.79628.51
Cash Flow per Share22.16-9.41-29.33122.08—
Free Cash Flow per Share0.62-41.24-55.8973.9773.97
Dividends per Share4.844.172.505.00—
Shares Outstanding (cr)28.228.228.228.228.2
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.